Open Stage Seminar Oct. 11 (Thu.)  14:10 ~ 14:20

Lonza Japan Pharma & Biotech

Takahiro Nakano

Senior sales manager APAC, Cell therapy/gene therapy, Pharma & Biotech

Enabling the development of commercially-viable cell therapy products: our approach and experience

The cell and gene therapy market has experienced an immense growth driven by recent landmark approvals and commercial launches. While these products are showing remarkable therapeutic efficacy, there is an emerging need for robust manufacturing platforms capable of both scaling up and scaling out, while 1) achieving consistent product of highest quality and safety and 2) reducing cost. During this session, we will discuss how innovative platforms and solutions may help overcome some of the issues faced by the industry.

Window Close